Rank | Gene Set | Z-score |
---|---|---|
1 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.01760800 |
2 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.01760800 |
3 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.01760800 |
4 | modulation by symbiont of host immune response (GO:0052553) | 5.01760800 |
5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.01760800 |
6 | modulation by symbiont of host defense response (GO:0052031) | 5.01760800 |
7 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.96722320 |
8 | detection of other organism (GO:0098543) | 4.74736042 |
9 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.71944044 |
10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.71944044 |
11 | detection of bacterium (GO:0016045) | 4.53076065 |
12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.50649574 |
13 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.50320315 |
14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43097265 |
15 | detection of external biotic stimulus (GO:0098581) | 4.17557957 |
16 | macrophage activation involved in immune response (GO:0002281) | 3.98216626 |
17 | positive regulation of B cell differentiation (GO:0045579) | 3.95180284 |
18 | immunoglobulin mediated immune response (GO:0016064) | 3.85925500 |
19 | neutrophil activation involved in immune response (GO:0002283) | 3.75339073 |
20 | regulation of gamma-delta T cell activation (GO:0046643) | 3.71955341 |
21 | detection of biotic stimulus (GO:0009595) | 3.67997725 |
22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.66388630 |
23 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.66182418 |
24 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.61926939 |
25 | positive regulation of interferon-alpha production (GO:0032727) | 3.61397036 |
26 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.59754501 |
27 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.51304003 |
28 | response to peptidoglycan (GO:0032494) | 3.48394952 |
29 | response to muramyl dipeptide (GO:0032495) | 3.46147581 |
30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.44589951 |
31 | regulation of leukocyte degranulation (GO:0043300) | 3.44507830 |
32 | regulation of interferon-alpha production (GO:0032647) | 3.44212810 |
33 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.39680913 |
34 | apoptotic cell clearance (GO:0043277) | 3.34951977 |
35 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.34945259 |
36 | regulation of cholesterol storage (GO:0010885) | 3.32013341 |
37 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.29911902 |
38 | germinal center formation (GO:0002467) | 3.26605010 |
39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.23076400 |
40 | response to host immune response (GO:0052572) | 3.23076400 |
41 | positive regulation of antigen processing and presentation (GO:0002579) | 3.18689456 |
42 | negative regulation of T cell mediated immunity (GO:0002710) | 3.16689493 |
43 | mannose metabolic process (GO:0006013) | 3.16604271 |
44 | positive regulation of mast cell activation (GO:0033005) | 3.16221384 |
45 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.14238167 |
46 | regulation of B cell differentiation (GO:0045577) | 3.12404555 |
47 | response to host defenses (GO:0052200) | 3.07358075 |
48 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.07358075 |
49 | response to host (GO:0075136) | 3.07358075 |
50 | B cell receptor signaling pathway (GO:0050853) | 3.07271562 |
51 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.06715449 |
52 | response to interleukin-15 (GO:0070672) | 3.05873030 |
53 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.01600816 |
54 | regulation of tolerance induction (GO:0002643) | 3.00906430 |
55 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.00797076 |
56 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.00721610 |
57 | pinocytosis (GO:0006907) | 3.00298797 |
58 | respiratory burst (GO:0045730) | 2.99588073 |
59 | regulation of mast cell activation (GO:0033003) | 2.99464001 |
60 | regulation of T cell tolerance induction (GO:0002664) | 2.99155772 |
61 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89762867 |
62 | regulation of regulated secretory pathway (GO:1903305) | 2.88396553 |
63 | negative thymic T cell selection (GO:0045060) | 2.87859355 |
64 | negative regulation of interleukin-12 production (GO:0032695) | 2.87528694 |
65 | I-kappaB phosphorylation (GO:0007252) | 2.86956128 |
66 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.84556711 |
67 | positive regulation of mast cell degranulation (GO:0043306) | 2.82226153 |
68 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.82226153 |
69 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.81647829 |
70 | negative regulation of innate immune response (GO:0045824) | 2.81486108 |
71 | NIK/NF-kappaB signaling (GO:0038061) | 2.80207044 |
72 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.78376219 |
73 | positive thymic T cell selection (GO:0045059) | 2.78235114 |
74 | negative regulation of granulocyte differentiation (GO:0030853) | 2.78211042 |
75 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.78079255 |
76 | negative regulation of cell killing (GO:0031342) | 2.78079255 |
77 | B cell mediated immunity (GO:0019724) | 2.77899967 |
78 | neutrophil activation (GO:0042119) | 2.77676355 |
79 | response to laminar fluid shear stress (GO:0034616) | 2.77373927 |
80 | myeloid cell activation involved in immune response (GO:0002275) | 2.76756486 |
81 | low-density lipoprotein particle clearance (GO:0034383) | 2.76738655 |
82 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.75636786 |
83 | leukocyte degranulation (GO:0043299) | 2.73870349 |
84 | granulocyte activation (GO:0036230) | 2.73344643 |
85 | negative regulation of lipid storage (GO:0010888) | 2.73186555 |
86 | negative T cell selection (GO:0043383) | 2.72404480 |
87 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.70330242 |
88 | detection of molecule of bacterial origin (GO:0032490) | 2.68323692 |
89 | response to type I interferon (GO:0034340) | 2.67806630 |
90 | positive regulation of cholesterol efflux (GO:0010875) | 2.67712459 |
91 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.67296040 |
92 | T cell selection (GO:0045058) | 2.66082605 |
93 | defense response to protozoan (GO:0042832) | 2.65812040 |
94 | T-helper 1 type immune response (GO:0042088) | 2.65807643 |
95 | myeloid leukocyte activation (GO:0002274) | 2.65610471 |
96 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.65060957 |
97 | neutrophil chemotaxis (GO:0030593) | 2.63296428 |
98 | positive regulation of interferon-beta production (GO:0032728) | 2.62488463 |
99 | type I interferon signaling pathway (GO:0060337) | 2.62161351 |
100 | cellular response to type I interferon (GO:0071357) | 2.62161351 |
101 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.62031764 |
102 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61334009 |
103 | macrophage activation (GO:0042116) | 2.60739497 |
104 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.59731038 |
105 | regulation of antigen processing and presentation (GO:0002577) | 2.59714554 |
106 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.59702780 |
107 | positive regulation of histone deacetylation (GO:0031065) | 2.58289501 |
108 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.58204231 |
109 | positive regulation of sterol transport (GO:0032373) | 2.57144792 |
110 | positive regulation of cholesterol transport (GO:0032376) | 2.57144792 |
111 | microglial cell activation (GO:0001774) | 2.57055664 |
112 | phospholipid homeostasis (GO:0055091) | 2.55819198 |
113 | negative regulation of interleukin-6 production (GO:0032715) | 2.53106359 |
114 | regulation of mast cell degranulation (GO:0043304) | 2.52956180 |
115 | neutrophil mediated immunity (GO:0002446) | 2.52583946 |
116 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.50378320 |
117 | cellular extravasation (GO:0045123) | 2.49185729 |
118 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.48069709 |
119 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.46840301 |
120 | complement activation, alternative pathway (GO:0006957) | 2.45249030 |
121 | response to protozoan (GO:0001562) | 2.45231153 |
122 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.45060272 |
123 | leukocyte aggregation (GO:0070486) | 2.43848808 |
124 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.42370032 |
125 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.42188217 |
126 | natural killer cell mediated immunity (GO:0002228) | 2.42188217 |
127 | plasma lipoprotein particle clearance (GO:0034381) | 2.40375832 |
128 | mature B cell differentiation (GO:0002335) | 2.39126385 |
129 | regulation of phagocytosis (GO:0050764) | 2.38573590 |
130 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.37689963 |
131 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.36537220 |
132 | regulation of integrin activation (GO:0033623) | 2.36232094 |
133 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.35127845 |
134 | adaptive immune response based on somatic recombination of immune receptors built from immunoglobuli | 2.35100414 |
135 | cytokine secretion (GO:0050663) | 2.34643319 |
136 | B cell homeostasis (GO:0001782) | 2.34385546 |
Rank | Gene Set | Z-score |
---|---|---|
1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.87654700 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.03405841 |
3 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.26378905 |
4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.14777888 |
5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.12012908 |
6 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.99214030 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.98047526 |
8 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97378615 |
9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.79842927 |
10 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.79811792 |
11 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.67175364 |
12 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.65596889 |
13 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.61978913 |
14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.61898321 |
15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.56990546 |
16 | * VDR_21846776_ChIP-Seq_THP-1_Human | 2.54219452 |
17 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.46407268 |
18 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.44489505 |
19 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.41054520 |
20 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.36466214 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.33888149 |
22 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.21621934 |
23 | MYC_22102868_ChIP-Seq_BL_Human | 2.21363940 |
24 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.19451028 |
25 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.10038170 |
26 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.09004370 |
27 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00479126 |
28 | MAF_26560356_Chip-Seq_TH1_Human | 2.00282071 |
29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.96214994 |
30 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.95136916 |
31 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.88680307 |
32 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.87843041 |
33 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.86868589 |
34 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.85600453 |
35 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.84299977 |
36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80915375 |
37 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.75783545 |
38 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.74382725 |
39 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.73631338 |
40 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.72646180 |
41 | MYB_26560356_Chip-Seq_TH2_Human | 1.68468352 |
42 | MYB_26560356_Chip-Seq_TH1_Human | 1.68429441 |
43 | UTX_26944678_Chip-Seq_JUKART_Human | 1.67377809 |
44 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66731567 |
45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.60601665 |
46 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.58510112 |
47 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.58241590 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57322472 |
49 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.51756496 |
50 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.51645354 |
51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50672186 |
52 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.44811748 |
53 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44769836 |
54 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.43097955 |
55 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42967245 |
56 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.42333943 |
57 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41899737 |
58 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.39758540 |
59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.38803347 |
60 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.38197894 |
61 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.36067323 |
62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.35970986 |
63 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.34837608 |
64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32846301 |
65 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.32048416 |
66 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.30974993 |
67 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.30245181 |
68 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.28679341 |
69 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28310568 |
70 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.28126229 |
71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27635383 |
72 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.25512347 |
73 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.25428185 |
74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.24589169 |
75 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24524083 |
76 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.23756556 |
77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21872843 |
78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.18381526 |
79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.17491505 |
80 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.17297724 |
81 | MAF_26560356_Chip-Seq_TH2_Human | 1.17042426 |
82 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.16491890 |
83 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15324473 |
84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14137717 |
85 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12220595 |
86 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.12015324 |
87 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.11476833 |
88 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.10514397 |
89 | GATA1_19941826_ChIP-Seq_K562_Human | 1.10021438 |
90 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08965302 |
91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.07869451 |
92 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.07690051 |
93 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07248518 |
94 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.06433876 |
95 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.06255199 |
96 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.06173883 |
97 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04881277 |
98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04344310 |
99 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04221712 |
100 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.04186363 |
101 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03325310 |
102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02341140 |
103 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.00633297 |
104 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.99866004 |
105 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99547613 |
106 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.99449978 |
107 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98189439 |
108 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97091085 |
109 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96714092 |
110 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.96357447 |
111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.96028734 |
112 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.94992317 |
113 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.93714416 |
114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92607989 |
115 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92492532 |
116 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91261915 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0001835_abnormal_antigen_presentation | 3.23843053 |
2 | MP0003303_peritoneal_inflammation | 2.95973166 |
3 | MP0005058_abnormal_lysosome_morphology | 2.92849167 |
4 | MP0003436_decreased_susceptibility_to | 2.68398462 |
5 | MP0000685_abnormal_immune_system | 2.65935019 |
6 | MP0009840_abnormal_foam_cell | 2.54764697 |
7 | MP0000569_abnormal_digit_pigmentation | 2.54011615 |
8 | MP0003191_abnormal_cellular_cholesterol | 2.53637415 |
9 | MP0005387_immune_system_phenotype | 2.48323725 |
10 | MP0001790_abnormal_immune_system | 2.48323725 |
11 | MP0009278_abnormal_bone_marrow | 2.40385033 |
12 | MP0008260_abnormal_autophagy | 2.39745823 |
13 | MP0001800_abnormal_humoral_immune | 2.36392416 |
14 | MP0002419_abnormal_innate_immunity | 2.36284783 |
15 | MP0003300_gastrointestinal_ulcer | 2.34190377 |
16 | MP0005464_abnormal_platelet_physiology | 2.25367848 |
17 | MP0003172_abnormal_lysosome_physiology | 2.24493658 |
18 | MP0002139_abnormal_hepatobiliary_system | 2.23667968 |
19 | MP0002452_abnormal_antigen_presenting | 2.16451837 |
20 | MP0005025_abnormal_response_to | 2.14747212 |
21 | MP0005451_abnormal_body_composition | 2.14614419 |
22 | MP0005000_abnormal_immune_tolerance | 2.10882384 |
23 | MP0009785_altered_susceptibility_to | 2.05053042 |
24 | MP0002723_abnormal_immune_serum | 1.98302112 |
25 | MP0006082_CNS_inflammation | 1.88243157 |
26 | MP0004947_skin_inflammation | 1.88198196 |
27 | MP0003828_pulmonary_edema | 1.80381331 |
28 | MP0002420_abnormal_adaptive_immunity | 1.79341186 |
29 | MP0001819_abnormal_immune_cell | 1.78860998 |
30 | MP0002166_altered_tumor_susceptibility | 1.73488565 |
31 | MP0008438_abnormal_cutaneous_collagen | 1.73355910 |
32 | MP0005671_abnormal_response_to | 1.70628319 |
33 | MP0004510_myositis | 1.68945724 |
34 | MP0002148_abnormal_hypersensitivity_rea | 1.65278012 |
35 | MP0005360_urolithiasis | 1.60632297 |
36 | MP0003724_increased_susceptibility_to | 1.59315881 |
37 | MP0001845_abnormal_inflammatory_respons | 1.53861699 |
38 | MP0002405_respiratory_system_inflammati | 1.53201087 |
39 | MP0001533_abnormal_skeleton_physiology | 1.52518554 |
40 | MP0001853_heart_inflammation | 1.52377545 |
41 | MP0005365_abnormal_bile_salt | 1.51415040 |
42 | MP0003705_abnormal_hypodermis_morpholog | 1.48057718 |
43 | MP0008469_abnormal_protein_level | 1.47614815 |
44 | MP0005174_abnormal_tail_pigmentation | 1.47220397 |
45 | MP0005397_hematopoietic_system_phenotyp | 1.46525321 |
46 | MP0001545_abnormal_hematopoietic_system | 1.46525321 |
47 | MP0010155_abnormal_intestine_physiology | 1.46110816 |
48 | MP0002396_abnormal_hematopoietic_system | 1.44674305 |
49 | MP0002398_abnormal_bone_marrow | 1.44370664 |
50 | MP0000716_abnormal_immune_system | 1.43619256 |
51 | MP0001958_emphysema | 1.42932110 |
52 | MP0000689_abnormal_spleen_morphology | 1.42394009 |
53 | MP0003566_abnormal_cell_adhesion | 1.41410144 |
54 | MP0003690_abnormal_glial_cell | 1.40877363 |
55 | MP0004883_abnormal_blood_vessel | 1.40850735 |
56 | MP0003183_abnormal_peptide_metabolism | 1.40576791 |
57 | MP0002132_abnormal_respiratory_system | 1.40243303 |
58 | MP0005083_abnormal_biliary_tract | 1.39300912 |
59 | MP0000465_gastrointestinal_hemorrhage | 1.39103778 |
60 | MP0001873_stomach_inflammation | 1.31698772 |
61 | MP0004381_abnormal_hair_follicle | 1.30629728 |
62 | MP0000604_amyloidosis | 1.28137195 |
63 | MP0002006_tumorigenesis | 1.22936242 |
64 | MP0002722_abnormal_immune_system | 1.22516823 |
65 | MP0003448_altered_tumor_morphology | 1.21660027 |
66 | MP0002429_abnormal_blood_cell | 1.20996202 |
67 | MP0000609_abnormal_liver_physiology | 1.18985031 |
68 | MP0003252_abnormal_bile_duct | 1.17609563 |
69 | MP0002933_joint_inflammation | 1.17458865 |
70 | MP0005164_abnormal_response_to | 1.15558599 |
71 | MP0005076_abnormal_cell_differentiation | 1.10430045 |
72 | MP0009764_decreased_sensitivity_to | 1.09352074 |
73 | MP0004808_abnormal_hematopoietic_stem | 1.08736302 |
74 | MP0000343_altered_response_to | 1.08693147 |
75 | MP0009333_abnormal_splenocyte_physiolog | 1.08659180 |
76 | MP0005023_abnormal_wound_healing | 1.08552503 |
77 | MP0010329_abnormal_lipoprotein_level | 1.08117675 |
78 | MP0002254_reproductive_system_inflammat | 1.08057054 |
79 | MP0002998_abnormal_bone_remodeling | 1.05845844 |
80 | MP0009763_increased_sensitivity_to | 1.03251744 |
81 | MP0008004_abnormal_stomach_pH | 1.02251776 |
82 | MP0003075_altered_response_to | 1.01467217 |
83 | MP0010307_abnormal_tumor_latency | 0.99910468 |
84 | MP0000371_diluted_coat_color | 0.99457727 |
85 | MP0003279_aneurysm | 0.97854595 |
86 | MP0000858_altered_metastatic_potential | 0.96801606 |
87 | MP0003763_abnormal_thymus_physiology | 0.94444420 |
88 | MP0002138_abnormal_hepatobiliary_system | 0.93523692 |
89 | MP0001851_eye_inflammation | 0.93269827 |
90 | MP0003656_abnormal_erythrocyte_physiolo | 0.93028307 |
91 | MP0005390_skeleton_phenotype | 0.91665295 |
92 | MP0005085_abnormal_gallbladder_physiolo | 0.91207307 |
93 | MP0000249_abnormal_blood_vessel | 0.87210347 |
94 | MP0003329_amyloid_beta_deposits | 0.86351128 |
95 | MP0000598_abnormal_liver_morphology | 0.85458442 |
96 | MP0005257_abnormal_intraocular_pressure | 0.83963787 |
97 | MP0000767_abnormal_smooth_muscle | 0.83300004 |
98 | MP0005319_abnormal_enzyme/_coenzyme | 0.83265563 |
99 | MP0010352_gastrointestinal_tract_polyps | 0.82939911 |
100 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82530402 |
101 | MP0003866_abnormal_defecation | 0.81782485 |
102 | MP0005310_abnormal_salivary_gland | 0.81398648 |
103 | MP0003453_abnormal_keratinocyte_physiol | 0.81170647 |
104 | MP0002928_abnormal_bile_duct | 0.80233913 |
105 | MP0002060_abnormal_skin_morphology | 0.79909576 |
106 | MP0001849_ear_inflammation | 0.78878697 |
107 | MP0000703_abnormal_thymus_morphology | 0.78746525 |
108 | MP0000015_abnormal_ear_pigmentation | 0.78489257 |
109 | MP0003795_abnormal_bone_structure | 0.77749624 |
110 | MP0005075_abnormal_melanosome_morpholog | 0.77329835 |
111 | MP0003045_fibrosis | 0.77286092 |
112 | MP0003091_abnormal_cell_migration | 0.77268288 |
113 | MP0005166_decreased_susceptibility_to | 0.76219385 |
114 | MP0002136_abnormal_kidney_physiology | 0.74816620 |
115 | MP0001663_abnormal_digestive_system | 0.74742191 |
116 | MP0002277_abnormal_respiratory_mucosa | 0.69800322 |
117 | MP0004858_abnormal_nervous_system | 0.68525092 |
118 | MP0002877_abnormal_melanocyte_morpholog | 0.68074383 |
119 | MP0000490_abnormal_crypts_of | 0.66071568 |
120 | MP0008874_decreased_physiological_sensi | 0.64821327 |
121 | MP0000920_abnormal_myelination | 0.61452109 |
122 | MP0005388_respiratory_system_phenotype | 0.57293930 |
123 | MP0002133_abnormal_respiratory_system | 0.57293930 |
124 | MP0009765_abnormal_xenobiotic_induced | 0.57011682 |
125 | MP0003806_abnormal_nucleotide_metabolis | 0.56590213 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Recurrent abscess formation (HP:0002722) | 5.08685312 |
2 | Recurrent bacterial skin infections (HP:0005406) | 4.90305439 |
3 | Eczematoid dermatitis (HP:0000976) | 4.58918839 |
4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.24715283 |
5 | Systemic lupus erythematosus (HP:0002725) | 4.04826365 |
6 | Vacuolated lymphocytes (HP:0001922) | 3.51795127 |
7 | Gastrointestinal infarctions (HP:0005244) | 3.51384148 |
8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.44983504 |
9 | Increased cerebral lipofuscin (HP:0011813) | 3.41838334 |
10 | Abnormality of macrophages (HP:0004311) | 3.36471688 |
11 | Recurrent skin infections (HP:0001581) | 3.22504094 |
12 | Autoimmune thrombocytopenia (HP:0001973) | 3.18617074 |
13 | Periodontitis (HP:0000704) | 3.14778428 |
14 | Gingivitis (HP:0000230) | 3.13044862 |
15 | Cellulitis (HP:0100658) | 3.11433829 |
16 | Glomerulonephritis (HP:0000099) | 3.10240463 |
17 | Complement deficiency (HP:0004431) | 3.07257860 |
18 | Myocardial infarction (HP:0001658) | 3.05584319 |
19 | Mediastinal lymphadenopathy (HP:0100721) | 3.04470082 |
20 | Recurrent fungal infections (HP:0002841) | 3.00703679 |
21 | Dysostosis multiplex (HP:0000943) | 3.00404169 |
22 | Gingival bleeding (HP:0000225) | 2.97939971 |
23 | Hematochezia (HP:0002573) | 2.93385120 |
24 | Keratoconjunctivitis sicca (HP:0001097) | 2.93178535 |
25 | Myositis (HP:0100614) | 2.92155220 |
26 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.88353907 |
27 | Colitis (HP:0002583) | 2.88295165 |
28 | Recurrent viral infections (HP:0004429) | 2.87220613 |
29 | Spontaneous hematomas (HP:0007420) | 2.86478662 |
30 | Pustule (HP:0200039) | 2.80086441 |
31 | Encephalitis (HP:0002383) | 2.77220143 |
32 | Axonal loss (HP:0003447) | 2.75493472 |
33 | Chronic otitis media (HP:0000389) | 2.73175600 |
34 | Inflammation of the large intestine (HP:0002037) | 2.67532871 |
35 | Stomatitis (HP:0010280) | 2.66697916 |
36 | Abnormality of complement system (HP:0005339) | 2.66654626 |
37 | Mucopolysacchariduria (HP:0008155) | 2.66642616 |
38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.66642616 |
39 | Chest pain (HP:0100749) | 2.64311701 |
40 | Joint hemorrhage (HP:0005261) | 2.62563602 |
41 | Keratoconjunctivitis (HP:0001096) | 2.62514580 |
42 | Gastrointestinal inflammation (HP:0004386) | 2.60996461 |
43 | Cerebral aneurysm (HP:0004944) | 2.59959220 |
44 | Hemoptysis (HP:0002105) | 2.58267685 |
45 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.58244746 |
46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.58244746 |
47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.58244746 |
48 | Amyloidosis (HP:0011034) | 2.53795763 |
49 | T lymphocytopenia (HP:0005403) | 2.53002031 |
50 | Vasculitis (HP:0002633) | 2.52341794 |
51 | Interstitial pulmonary disease (HP:0006530) | 2.50265684 |
52 | Nephritis (HP:0000123) | 2.45560291 |
53 | Deep venous thrombosis (HP:0002625) | 2.44940706 |
54 | Osteomyelitis (HP:0002754) | 2.42351615 |
55 | Purpura (HP:0000979) | 2.40595990 |
56 | Epistaxis (HP:0000421) | 2.40498960 |
57 | Prolonged bleeding time (HP:0003010) | 2.40101855 |
58 | Meningitis (HP:0001287) | 2.39551936 |
59 | Orchitis (HP:0100796) | 2.36416260 |
60 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.36391695 |
61 | Abnormality of the nasal mucosa (HP:0000433) | 2.35748469 |
62 | Mitral stenosis (HP:0001718) | 2.35218336 |
63 | Abnormality of T cell number (HP:0011839) | 2.34619249 |
64 | Nasal polyposis (HP:0100582) | 2.33797082 |
65 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.32094569 |
66 | Episodic fever (HP:0001954) | 2.31696568 |
67 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.29630095 |
68 | Osteolytic defects of the hand bones (HP:0009699) | 2.29630095 |
69 | Impaired platelet aggregation (HP:0003540) | 2.28879029 |
70 | Abnormal platelet function (HP:0011869) | 2.28879029 |
71 | Thoracic kyphosis (HP:0002942) | 2.27426393 |
72 | Urticaria (HP:0001025) | 2.25985844 |
73 | Xanthomatosis (HP:0000991) | 2.25540360 |
74 | Loss of speech (HP:0002371) | 2.25180883 |
75 | Pulmonary embolism (HP:0002204) | 2.24725912 |
76 | Abnormality of glycolipid metabolism (HP:0010969) | 2.23500516 |
77 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.23500516 |
78 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.23500516 |
79 | Emphysema (HP:0002097) | 2.18014423 |
80 | Obstructive lung disease (HP:0006536) | 2.16723553 |
81 | Chronic obstructive pulmonary disease (HP:0006510) | 2.16723553 |
82 | IgM deficiency (HP:0002850) | 2.15203968 |
83 | Arterial thrombosis (HP:0004420) | 2.12152359 |
84 | Slow saccadic eye movements (HP:0000514) | 2.11467223 |
85 | Menorrhagia (HP:0000132) | 2.11041816 |
86 | Recurrent bronchitis (HP:0002837) | 2.09418393 |
87 | Recurrent cutaneous fungal infections (HP:0011370) | 2.09223228 |
88 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.09223228 |
89 | Premature loss of primary teeth (HP:0006323) | 2.09019822 |
90 | Gastrointestinal stroma tumor (HP:0100723) | 2.08628642 |
91 | Agammaglobulinemia (HP:0004432) | 2.08141400 |
92 | Hypochromic anemia (HP:0001931) | 2.07256523 |
93 | Leukocytosis (HP:0001974) | 2.07192375 |
94 | Anorexia (HP:0002039) | 2.05828295 |
95 | Abnormality of the peritoneum (HP:0002585) | 2.03710337 |
96 | Hepatosplenomegaly (HP:0001433) | 2.03484239 |
97 | Abnormality of the common coagulation pathway (HP:0010990) | 2.03109444 |
98 | Panhypogammaglobulinemia (HP:0003139) | 2.02753402 |
99 | Granulocytopenia (HP:0001913) | 1.99864381 |
100 | Abnormality of the fingertips (HP:0001211) | 1.98226236 |
101 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.98084359 |
102 | Abnormality of the thoracic spine (HP:0100711) | 1.97948168 |
103 | Malnutrition (HP:0004395) | 1.97558822 |
104 | Sepsis (HP:0100806) | 1.96861434 |
105 | Abnormality of T cells (HP:0002843) | 1.96568069 |
106 | Vertebral compression fractures (HP:0002953) | 1.95377445 |
107 | Peritonitis (HP:0002586) | 1.93920054 |
108 | Aortic aneurysm (HP:0004942) | 1.93101234 |
109 | Hypergammaglobulinemia (HP:0010702) | 1.92338615 |
110 | Restrictive lung disease (HP:0002091) | 1.92007735 |
111 | Increased IgE level (HP:0003212) | 1.91967382 |
112 | Polycythemia (HP:0001901) | 1.89819966 |
113 | Viral hepatitis (HP:0006562) | 1.89699661 |
114 | Lymphopenia (HP:0001888) | 1.89618098 |
115 | Pathologic fracture (HP:0002756) | 1.89535300 |
116 | Skin ulcer (HP:0200042) | 1.89356518 |
117 | Hypochromic microcytic anemia (HP:0004840) | 1.88949858 |
118 | Abnormality of iron homeostasis (HP:0011031) | 1.86584745 |
119 | Increased IgM level (HP:0003496) | 1.85839345 |
120 | Increased CSF protein (HP:0002922) | 1.85633276 |
121 | Glomerulopathy (HP:0100820) | 1.85195779 |
122 | Pulmonary infiltrates (HP:0002113) | 1.84395715 |
123 | Spondylolisthesis (HP:0003302) | 1.83519448 |
124 | Disinhibition (HP:0000734) | 1.83500249 |
125 | Thick nail (HP:0001805) | 1.83084663 |
126 | Abnormality of the endocardium (HP:0004306) | 1.81778840 |
127 | Increased serum ferritin (HP:0003281) | 1.81522257 |
128 | Abnormality of the pleura (HP:0002103) | 1.81472976 |
129 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.81263256 |
130 | Abnormal platelet volume (HP:0011876) | 1.80056474 |
131 | Optic neuritis (HP:0100653) | 1.79767824 |
132 | Retrobulbar optic neuritis (HP:0100654) | 1.79767824 |
133 | Ulnar bowing (HP:0003031) | 1.78861327 |
134 | Petechiae (HP:0000967) | 1.78563731 |
135 | Thrombocytosis (HP:0001894) | 1.77856933 |
136 | Esophageal varix (HP:0002040) | 1.76754007 |
137 | Bruising susceptibility (HP:0000978) | 1.76370627 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ERN1 | 3.55431104 |
2 | MAP4K1 | 3.53912363 |
3 | PRPF4B | 2.83971918 |
4 | IRAK3 | 2.78125038 |
5 | TYK2 | 2.71873110 |
6 | TRIB3 | 2.69038752 |
7 | KIT | 2.50366017 |
8 | TBK1 | 2.43934005 |
9 | BLK | 2.34189412 |
10 | TAOK3 | 2.31892932 |
11 | MAP3K14 | 2.25525043 |
12 | TGFBR2 | 2.12190887 |
13 | IRAK4 | 2.03617431 |
14 | CSF1R | 2.02442175 |
15 | PKN2 | 2.00042577 |
16 | EPHB1 | 1.93846933 |
17 | MAP3K10 | 1.93531053 |
18 | RIPK4 | 1.93135724 |
19 | JAK3 | 1.90895332 |
20 | IKBKE | 1.82428111 |
21 | EEF2K | 1.76192121 |
22 | JAK1 | 1.75091281 |
23 | TAOK1 | 1.71099398 |
24 | ZAP70 | 1.69709445 |
25 | TTN | 1.64486400 |
26 | BTK | 1.61768684 |
27 | MAP2K3 | 1.61277318 |
28 | IKBKB | 1.59289154 |
29 | FGFR4 | 1.55934080 |
30 | STK10 | 1.53244002 |
31 | CSK | 1.52535374 |
32 | CAMK1D | 1.49745378 |
33 | SMG1 | 1.41317967 |
34 | CDK12 | 1.40303651 |
35 | MAP3K13 | 1.38482333 |
36 | HCK | 1.37256843 |
37 | FLT3 | 1.36573481 |
38 | SIK1 | 1.35588253 |
39 | LRRK2 | 1.24658484 |
40 | MARK2 | 1.23589428 |
41 | SYK | 1.21838554 |
42 | GRK6 | 1.18633286 |
43 | FES | 1.18389007 |
44 | KSR2 | 1.17377458 |
45 | CDC42BPA | 1.16436936 |
46 | CAMK1G | 1.14628498 |
47 | TAOK2 | 1.10152696 |
48 | LCK | 1.08593343 |
49 | SIK2 | 1.08532025 |
50 | JAK2 | 1.07771972 |
51 | SIK3 | 1.06548695 |
52 | RIPK1 | 1.04912059 |
53 | CHUK | 1.04745593 |
54 | PRKD2 | 1.00404588 |
55 | TXK | 0.98636283 |
56 | * PTK6 | 0.98612775 |
57 | NEK9 | 0.97268349 |
58 | TEC | 0.94645180 |
59 | ITK | 0.93350291 |
60 | LYN | 0.92417019 |
61 | RPS6KA4 | 0.90001740 |
62 | IRAK2 | 0.87920518 |
63 | YES1 | 0.87075612 |
64 | PIM1 | 0.86444600 |
65 | FGFR3 | 0.86329128 |
66 | MATK | 0.86114852 |
67 | MAP3K6 | 0.84952087 |
68 | EPHA3 | 0.84137143 |
69 | MAP3K3 | 0.83701638 |
70 | IRAK1 | 0.81343496 |
71 | ICK | 0.75402563 |
72 | CDK6 | 0.75144106 |
73 | MARK3 | 0.74266358 |
74 | PAK4 | 0.73465864 |
75 | TRPM7 | 0.70846055 |
76 | MAPK7 | 0.69994233 |
77 | MAP3K7 | 0.68604334 |
78 | FGR | 0.65970207 |
79 | BMPR2 | 0.63511007 |
80 | MAP3K2 | 0.63006787 |
81 | SCYL2 | 0.62160115 |
82 | SGK3 | 0.61894454 |
83 | CLK1 | 0.61384119 |
84 | TESK2 | 0.60415665 |
85 | FYN | 0.58807868 |
86 | EGFR | 0.57000597 |
87 | BMX | 0.56752974 |
88 | STK4 | 0.56387695 |
89 | PIK3CG | 0.55460969 |
90 | HIPK2 | 0.54981191 |
91 | RET | 0.54114173 |
92 | ABL1 | 0.51245876 |
93 | PDGFRB | 0.50977031 |
94 | MAPK11 | 0.49692351 |
95 | PRKCH | 0.49439824 |
96 | MTOR | 0.49221723 |
97 | RPS6KA6 | 0.48700682 |
98 | CDK4 | 0.48086055 |
99 | PDK1 | 0.45672202 |
100 | PTK2B | 0.45462439 |
101 | STK38 | 0.45449379 |
102 | KDR | 0.44623427 |
103 | MAP3K5 | 0.43113565 |
104 | PRKAA2 | 0.41231663 |
105 | NME2 | 0.39942501 |
106 | RPS6KC1 | 0.39833277 |
107 | RPS6KL1 | 0.39833277 |
108 | MAPKAPK2 | 0.38992656 |
109 | MAPK15 | 0.38755368 |
110 | CAMKK1 | 0.38139736 |
111 | PDGFRA | 0.37844847 |
112 | PDPK1 | 0.37815962 |
113 | MAP2K2 | 0.37640824 |
114 | MAP3K8 | 0.37545135 |
115 | PRKG2 | 0.37191896 |
116 | PAK2 | 0.37052151 |
117 | MAP2K6 | 0.36897701 |
118 | GRK7 | 0.36744162 |
119 | NEK2 | 0.35252930 |
120 | MAPK12 | 0.34332021 |
121 | MAPK4 | 0.34310774 |
122 | RPS6KA2 | 0.33573891 |
123 | MAP3K11 | 0.33551019 |
124 | PIM2 | 0.33320294 |
125 | PTK2 | 0.33085348 |
126 | DYRK1B | 0.32679995 |
127 | MAP3K1 | 0.32574973 |
128 | TNK2 | 0.32413928 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.42966753 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.58297208 |
3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.52726636 |
4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.49179603 |
5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.28530205 |
6 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15691420 |
7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.14805926 |
8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.10064363 |
9 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.98139537 |
10 | Other glycan degradation_Homo sapiens_hsa00511 | 1.90545607 |
11 | Lysosome_Homo sapiens_hsa04142 | 1.87442277 |
12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84151952 |
13 | Pertussis_Homo sapiens_hsa05133 | 1.83575840 |
14 | Malaria_Homo sapiens_hsa05144 | 1.70467098 |
15 | Tuberculosis_Homo sapiens_hsa05152 | 1.60741620 |
16 | Measles_Homo sapiens_hsa05162 | 1.60070605 |
17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55640033 |
18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52134543 |
19 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.51996415 |
20 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.51903114 |
21 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.48138004 |
22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.47830568 |
23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.42732391 |
24 | Legionellosis_Homo sapiens_hsa05134 | 1.41120572 |
25 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.40351830 |
26 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.38362571 |
27 | Influenza A_Homo sapiens_hsa05164 | 1.37388580 |
28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.34799754 |
29 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29631676 |
30 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28147351 |
31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.27936005 |
32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.26738394 |
33 | Apoptosis_Homo sapiens_hsa04210 | 1.25567387 |
34 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.20944907 |
35 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.20734929 |
36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.19740215 |
37 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.17853061 |
38 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17171232 |
39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.17071686 |
40 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.16496695 |
41 | ABC transporters_Homo sapiens_hsa02010 | 1.16155260 |
42 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.14591346 |
43 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.08306178 |
44 | Hepatitis C_Homo sapiens_hsa05160 | 1.04882337 |
45 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.04579465 |
46 | Lysine degradation_Homo sapiens_hsa00310 | 1.03737927 |
47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.03108190 |
48 | Insulin resistance_Homo sapiens_hsa04931 | 1.00696398 |
49 | Shigellosis_Homo sapiens_hsa05131 | 0.99087411 |
50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96775097 |
51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96631269 |
52 | Hepatitis B_Homo sapiens_hsa05161 | 0.94617120 |
53 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.92952230 |
54 | Platelet activation_Homo sapiens_hsa04611 | 0.92839476 |
55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90999934 |
56 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.90470374 |
57 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89173297 |
58 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.88975219 |
59 | Amoebiasis_Homo sapiens_hsa05146 | 0.88291081 |
60 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86397490 |
61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84242530 |
62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.82791079 |
63 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.82127378 |
64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80287081 |
65 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.79872378 |
66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.79753978 |
67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.79531201 |
68 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.76730676 |
69 | Histidine metabolism_Homo sapiens_hsa00340 | 0.74819547 |
70 | Phagosome_Homo sapiens_hsa04145 | 0.74651593 |
71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.74453589 |
72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73814088 |
73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.73625919 |
74 | Salmonella infection_Homo sapiens_hsa05132 | 0.73374055 |
75 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72716356 |
76 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71612052 |
77 | * Endocytosis_Homo sapiens_hsa04144 | 0.70920110 |
78 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.70623408 |
79 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.68948953 |
80 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.68177813 |
81 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.66040679 |
82 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64323215 |
83 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64287927 |
84 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63423370 |
85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.63248897 |
86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62757060 |
87 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62694681 |
88 | Allograft rejection_Homo sapiens_hsa05330 | 0.62477997 |
89 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60503616 |
90 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.60483519 |
91 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60209190 |
92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.59904499 |
93 | Bladder cancer_Homo sapiens_hsa05219 | 0.59735865 |
94 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59200822 |
95 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.58334376 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.58131060 |
97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.57713468 |
98 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.56888534 |
99 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55943085 |
100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.55697420 |
101 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54926089 |
102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.53195932 |
103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.53096066 |
104 | Peroxisome_Homo sapiens_hsa04146 | 0.52972943 |
105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.51289422 |
106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51052845 |
107 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48099233 |
108 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.48020716 |
109 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46737258 |
110 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46567386 |
111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.46482561 |
112 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46473172 |
113 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46414691 |
114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.46057457 |
115 | Focal adhesion_Homo sapiens_hsa04510 | 0.45983720 |
116 | Asthma_Homo sapiens_hsa05310 | 0.44835480 |
117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44087187 |
118 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.43747305 |
119 | Prostate cancer_Homo sapiens_hsa05215 | 0.42623998 |
120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42221497 |
121 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41737757 |
122 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41538431 |
123 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.40487241 |
124 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.39588338 |
125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.37944470 |
126 | Prion diseases_Homo sapiens_hsa05020 | 0.37619430 |
127 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.36664741 |
128 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36402794 |
129 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.35118306 |
130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33148713 |